Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lebkowski

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Antiviral Research|October 1, 1996
Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoysC Smith, S W Lee, E Wong, et al.
Gene Therapy|September 1, 1995
Generation of recombinant adeno-associated virus (rAAV) from an adenoviral vector and functional reconstitution of the NADPH-oxidaseA J Thrasher, M de Alwis, C M Casimir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancerR Philip, B Clary, E Brunette, et al.
Blood|July 15, 1995
Functional reconstitution of the NADPH-oxidase by adeno-associated virus gene transferA J Thrasher, M de Alwis, C M Casimir, et al.
Progress in Clinical and Biological Research|January 1, 1992
The AIS CELLector: a new technology for stem cell purificationT Okarma, J Lebkowski, L Schain, et al.
Cancer Gene Therapy|August 7, 1998
Transgene expression in dendritic cells to induce antigen-specific cytotoxic T cells in healthy donorsR Philip, E Brunette, J Ashton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 1997
Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activityJ S Miller, J Tessmer-Tuck, B A Pierson, et al.
Cytotherapy|April 30, 2010
Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipientsJ L Gajewski, S Nimer, R M Saliba, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Antiviral Research|October 1, 1996
Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoysC Smith, S W Lee, E Wong, et al.
Gene Therapy|September 1, 1995
Generation of recombinant adeno-associated virus (rAAV) from an adenoviral vector and functional reconstitution of the NADPH-oxidaseA J Thrasher, M de Alwis, C M Casimir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancerR Philip, B Clary, E Brunette, et al.
Blood|July 15, 1995
Functional reconstitution of the NADPH-oxidase by adeno-associated virus gene transferA J Thrasher, M de Alwis, C M Casimir, et al.
Progress in Clinical and Biological Research|January 1, 1992
The AIS CELLector: a new technology for stem cell purificationT Okarma, J Lebkowski, L Schain, et al.
Cancer Gene Therapy|August 7, 1998
Transgene expression in dendritic cells to induce antigen-specific cytotoxic T cells in healthy donorsR Philip, E Brunette, J Ashton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 1997
Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activityJ S Miller, J Tessmer-Tuck, B A Pierson, et al.
Cytotherapy|April 30, 2010
Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipientsJ L Gajewski, S Nimer, R M Saliba, et al.
Pageof 6